Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × futibatinib × 30 days × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Cholangiocarcinoma 1

Interventions

selinexor 1 mifamurtide 1 futibatinib 1 dodecyl maltoside 1 capmatinib 1 Sunitinib 1 Eflornithine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04507503 2026-03-10

Expanded Access Study of TAS-120 in Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

Taiho Oncology, Inc.

Approved for marketing

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡